Broadcom stock dips as CES Wi‑Fi 8 launch and CFO share-sale filing draw focus

Broadcom stock dips as CES Wi‑Fi 8 launch and CFO share-sale filing draw focus

New York, Jan 6, 2026, 09:51 a.m. ET — Regular session

  • Broadcom shares slid about 1% in early trading as chip stocks turned mixed.
  • Broadcom unveiled new Wi‑Fi 8 silicon at CES aimed at AI-heavy home networks.
  • An SEC filing showed CFO Kirsten Spears sold 30,000 shares on Dec. 31.

Broadcom (AVGO.O) shares slipped about 1% to $340 in early trading on Tuesday, after touching $338.37, as investors weighed a CES product rollout and fresh insider-trading disclosures.

The stock has become a key barometer for how long the AI hardware boom can run, given Broadcom’s role in networking chips and custom silicon used in big data centers. Traders are also watching whether new connectivity products can add growth without pressuring profitability.

Semiconductor names have been in focus at the CES show in Las Vegas, where Intel on Monday launched its Panther Lake laptop chip and highlighted a new manufacturing process, while rivals AMD and Nvidia also used the event to tout new AI products and partnerships. Reuters

Broadcom said it launched the BCM4918 accelerated processing unit, or APU, a chip that combines compute and networking functions, along with two new dual-band Wi‑Fi 8 devices, BCM6714 and BCM6719, aimed at helping broadband operators support real-time AI applications in the home. “Wi‑Fi 8 represents a turning point for the industry,” said Mark Gonikberg, a senior vice president and general manager at Broadcom. Finviz

A Form 4 filing — a required disclosure of trades by corporate insiders — showed Chief Financial Officer Kirsten M. Spears sold 30,000 Broadcom shares on Dec. 31 at prices around $347 a share. The filing listed 277,237 shares owned after the transaction, including restricted stock units. SEC

Broadcom last month forecast first-quarter fiscal 2026 revenue of about $19.1 billion and adjusted EBITDA of about 67% of revenue, after reporting record annual revenue for fiscal 2025, the company said. Investors have centered on whether AI-driven demand can offset softer conditions in other parts of its semiconductor business. PR Newswire

Analysts will look for any sign CES announcements translate into design wins with service providers, and for updates on the pace of custom AI-chip demand tied to big cloud customers. The stock has tended to react sharply to incremental signals on spending plans and product mix.

The risk is that profitability comes under renewed pressure: Broadcom warned in December that rising sales of lower-margin custom AI processors were squeezing margins, sparking worries that the business may be less lucrative than some investors expect. Reuters

The next catalyst is Broadcom’s quarterly report, which Yahoo Finance’s earnings calendar lists for March 4 after the market close. Yahoo

Stock Market Today

  • Belgium's Agomab Therapeutics Targets $212M Nasdaq IPO to Fund Crohn's Trials
    January 29, 2026, 11:36 AM EST. Belgian immunology biotech Agomab Therapeutics aims to raise up to $212.5 million in its Nasdaq debut under ticker AGMB. The company plans to sell 12.5 million shares priced $15-$17 each, targeting net proceeds of about $182 million to fund trials for its lead drug, ontunisertib, targeting fibrostenosing Crohn's disease. Ontunisertib, an ALK5 inhibitor acquired through Agomab's 2021 Origo Biopharma buyout, showed promising phase 2 results by affecting gene expression in the ileum. Additional funds will support phase 1 and 2 trials of AGMB-447, another ALK5 inhibitor for idiopathic pulmonary fibrosis. Agomab's IPO follows a biotech resurgence led by recent offerings from companies like Eikon Therapeutics and SpyGlass Pharma, spurring sector optimism for a strong 2026 exit environment.
Figure Technology Solutions stock (FIGR) hits a new high as rate-cut bets firm and crypto-linked names rally
Previous Story

Figure Technology Solutions stock (FIGR) hits a new high as rate-cut bets firm and crypto-linked names rally

Dow Jones today: DIA stock steadies near record as Fed’s Miran backs big rate cuts
Next Story

Dow Jones today: DIA stock steadies near record as Fed’s Miran backs big rate cuts

Go toTop